| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Eduardo L De Vito, Sergio G Monteiro, Santiago C Arc. Compartmental nutritional status and respiratory muscle function assessment in subjects with neuromuscular diseases. Medicina. vol 82. issue 2. 2022-04-13. PMID:35417383. |
cross-sectional study with als and dmd patients included in an institutional registry of neuromuscular diseases. |
2022-04-13 |
2023-08-13 |
human |
| Maria Egle De Stefano, Valentina Ferretti, Chiara Mozzett. Synaptic alterations as a neurodevelopmental trait of Duchenne muscular dystrophy. Neurobiology of disease. 2022-04-07. PMID:35390481. |
dystrophinopaties, e.g., duchenne muscular dystrophy (dmd), becker muscular dystrophy and x-linked dilated cardiomyopathy are inherited neuromuscular diseases, characterized by progressive muscular degeneration, which however associate with a significant impact on general system physiology. |
2022-04-07 |
2023-08-13 |
Not clear |
| Melanie Gartz, Margaret Haberman, Mariah J Prom, Margaret J Beatka, Jennifer L Strande, Michael W Lawlo. A Long-Term Study Evaluating the Effects of Nicorandil Treatment on Duchenne Muscular Dystrophy-Associated Cardiomyopathy in Journal of cardiovascular pharmacology and therapeutics. vol 27. 2022-03-30. PMID:35353647. |
a long-term study evaluating the effects of nicorandil treatment on duchenne muscular dystrophy-associated cardiomyopathy in duchenne muscular dystrophy (dmd) is a neuromuscular disease caused by dystrophin gene mutations affecting striated muscle. |
2022-03-30 |
2023-08-13 |
Not clear |
| Nermina Ferizovic, Jessica Summers, Igor Beitia Ortiz de Zárate, Christian Werner, Joel Jiang, Erik Landfeldt, Katharina Buesc. Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis. PloS one. vol 17. issue 3. 2022-03-25. PMID:35333888. |
duchenne muscular dystrophy (dmd) is a rare, severely debilitating, and fatal neuromuscular disease characterized by progressive muscle degeneration. |
2022-03-25 |
2023-08-13 |
Not clear |
| Julien Pichon, Mireille Ledevin, Thibaut Larcher, Frédéric Jamme, Karl Rouger, Laurence Dubrei. Label-free 3D characterization of cardiac fibrosis in muscular dystrophy using SHG imaging of cleared tissue. Biology of the cell. 2021-12-29. PMID:34964145. |
duchenne muscular dystrophy (dmd) is a neuromuscular disease caused by mutations in the gene encoding dystrophin. |
2021-12-29 |
2023-08-13 |
Not clear |
| Qianqian Li, Zhanni Chen, Hui Xiong, Ranran Li, Chenguang Yu, Jingjing Meng, Panlai Shi, Xiangdong Kon. Novel Partial Exon 51 Deletion in the Duchenne Muscular Dystrophy Gene Identified Frontiers in genetics. vol 12. 2021-12-13. PMID:34899847. |
novel partial exon 51 deletion in the duchenne muscular dystrophy gene identified duchenne muscular dystrophy (dmd), one of the most common progressive and severely disabling neuromuscular diseases in children, can be largely attributed to the loss of function of the |
2021-12-13 |
2023-08-13 |
Not clear |
| Jacob A Kaslow, Jonathan H Soslow, William B Burnette, Frank J Raucci, Tracy J Hills, Michaela G Ibach, Rita C Hebblethwaite, Kara M Arps, Andrew G Sokolo. Improving Access and Guideline Adherence in Pulmonary Care in Patients With Duchenne Muscular Dystrophy. Respiratory care. 2021-12-08. PMID:34876494. |
duchenne muscular dystrophy (dmd) is a devastating, progressive neuromuscular disease that results in cardiopulmonary failure and death. |
2021-12-08 |
2023-08-13 |
Not clear |
| Liang Wang, Huan Li, Yaqin Li, Min Xu, Jinfu Lin, Ziyu Liao, Zhong Pei, Cheng Zhan. Generation and characterization of an induced pluripotent stem cell line (ZSYYDNi001-A) from a patient with Duchenne muscular dystrophy carrying exon 51 deletion in the DMD gene. Stem cell research. vol 56. 2021-11-25. PMID:34619646. |
duchenne muscular dystrophy (dmd) is a common hereditary neuromuscular disease characterized by progressive muscle wasting and weakness. |
2021-11-25 |
2023-08-13 |
Not clear |
| Mahintaj Dara, Vahid Razban, Mohsen Mazloomrezaei, Maryam Ranjbar, Marjan Nourigorji, Mehdi Dianatpou. Dystrophin gene editing by CRISPR/Cas9 system in human skeletal muscle cell line (HSkMC). Iranian journal of basic medical sciences. vol 24. issue 8. 2021-11-23. PMID:34804433. |
duchene muscular dystrophy (dmd) is a progressive neuromuscular disease caused by mutations in the |
2021-11-23 |
2023-08-13 |
human |
| Lisa Wahlgren, Anna-Karin Kroksmark, Mar Tulinius, Kalliopi Sofo. One in five patients with Duchenne muscular dystrophy dies from other causes than cardiac or respiratory failure. European journal of epidemiology. 2021-11-21. PMID:34802091. |
patients with dmd were identified through the national quality registry for neuromuscular diseases in sweden, the swedish registry of respiratory failure, pathology laboratories, neurology and respiratory clinics, and the national network for neuromuscular diseases. |
2021-11-21 |
2023-08-13 |
Not clear |
| Christine Péladeau, Bernard J Jasmi. Targeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy. RNA biology. vol 18. issue 9. 2021-11-20. PMID:33164678. |
indeed, there has been growing interest over the past years in determining the therapeutic potential of iress for several disease conditions such as cancer, neurodegeneration and neuromuscular diseases including duchenne muscular dystrophy (dmd). |
2021-11-20 |
2023-08-13 |
Not clear |
| Eunyoung Choi, Taeyoung Ko. CRISPR technologies for the treatment of Duchenne muscular dystrophy. Molecular therapy : the journal of the American Society of Gene Therapy. vol 29. issue 11. 2021-11-17. PMID:33823301. |
the crispr-crispr-associated (cas) system is an attractive platform for the treatment of duchenne muscular dystrophy (dmd), which is a neuromuscular disease caused by mutations in the dmd gene. |
2021-11-17 |
2023-08-13 |
Not clear |
| Bram De Wel, Sofie Willaert, Aleksandra Nadaj-Pakleza, Anne-Catherine Aubé-Nathier, Dries Testelmans, Bertien Buyse, Kristl G Claey. Respiratory decline in adult patients with Becker muscular dystrophy: A longitudinal study. Neuromuscular disorders : NMD. vol 31. issue 3. 2021-11-15. PMID:33454189. |
becker muscular dystrophy (bmd) is a rare hereditary neuromuscular disease, caused by a genetic defect in the duchenne muscular dystrophy (dmd) gene. |
2021-11-15 |
2023-08-13 |
Not clear |
| Laurent Servais, Eric Camino, Aude Clement, Craig M McDonald, Jacek Lukawy, Linda P Lowes, Damien Eggenspieler, Francesca Cerreta, Paul Strijbo. First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases. Digital biomarkers. vol 5. issue 2. 2021-11-02. PMID:34723071. |
functional outcome measures used to assess efficacy in clinical trials of investigational treatments for rare neuromuscular diseases like duchenne muscular dystrophy (dmd) are performance-based tasks completed by the patient during hospital visits. |
2021-11-02 |
2023-08-13 |
Not clear |
| Deng-Qiu Xu, Lei Zhao, Si-Jia Li, Xiao-Fei Huang, Chun-Jie Li, Li-Xin Sun, Xi-Hua Li, Lu-Yong Zhang, Zhen-Zhou Jian. Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway. Acta pharmacologica Sinica. vol 42. issue 7. 2021-10-26. PMID:32939036. |
duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease caused by a mutation in the gene encoding the dystrophin protein. |
2021-10-26 |
2023-08-13 |
mouse |
| Laura A G Sulmonte, Katharine Bisordi, Elizabeth Ulm, Rachel Nusbau. Open communication of Duchenne muscular dystrophy facilitates disclosure process by parents to unaffected siblings. Journal of genetic counseling. vol 30. issue 1. 2021-10-15. PMID:32683768. |
duchenne muscular dystrophy (dmd) is a progressive childhood onset neuromuscular disease with no known cure. |
2021-10-15 |
2023-08-13 |
Not clear |
| Tatianna Wai Ying Wong, Abdalla Ahmed, Grace Yang, Eleonora Maino, Sydney Steiman, Elzbieta Hyatt, Parry Chan, Kyle Lindsay, Nicole Wong, Diane Golebiowski, Joel Schneider, Paul Delgado-Olguín, Evgueni A Ivakine, Ronald D Coh. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic Disease models & mechanisms. vol 13. issue 9. 2021-10-01. PMID:32988972. |
a novel mouse model of duchenne muscular dystrophy carrying a multi-exonic duchenne muscular dystrophy (dmd) is a life-threatening neuromuscular disease caused by the lack of dystrophin, resulting in progressive muscle wasting and locomotor dysfunctions. |
2021-10-01 |
2023-08-13 |
mouse |
| Erik Landfeldt, Joel Iff, Erik Henricso. Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular Dystrophy. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. vol 24. issue 10. 2021-10-01. PMID:34593173. |
the objective of this study was to examine the psychometric properties of the pediatric quality of life inventory 4.0 generic core scales (pedsql 4.0 gcs) in duchenne muscular dystrophy (dmd), a rare, severely debilitating, and ultimately fatal neuromuscular disease. |
2021-10-01 |
2023-08-13 |
Not clear |
| Hendrikje Schmidt, Arianna Felisatti, Michael von Aster, Jürgen Wilbert, Arpad von Moers, Martin H Fische. Neuromuscular Diseases Affect Number Representation and Processing: An Exploratory Study. Frontiers in psychology. vol 12. 2021-09-25. PMID:34552528. |
spinal muscular atrophy (sma) and duchenne muscular dystrophy (dmd) both are rare genetic neuromuscular diseases with progressive loss of motor ability. |
2021-09-25 |
2023-08-13 |
Not clear |
| Tiankun Hui, Hongyang Jing, Tian Zhou, Peng Chen, Ziyang Liu, Xia Dong, Min Yan, Dongyan Ren, Suqi Zou, Shunqi Wang, Erkang Fei, Daojun Hong, Xinsheng La. Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy. Human molecular genetics. vol 30. issue 17. 2021-09-15. PMID:33987657. |
duchenne muscular dystrophy (dmd) is an x-linked neuromuscular disease characterized by progressive wasting of skeletal muscles. |
2021-09-15 |
2023-08-13 |
mouse |